Barrow Neurological Institute has opened a new cutting-edge research center that is expected to revolutionize neurological research and expand Phoenix’s research footprint into the areas of environmental neurology and health equity.Continue reading→

The Platinum Seal is the highest level of recognition offered by Candid (formerly known as GuideStar) and is awarded to organizations that meet the highest standards of transparency and accountability.Continue reading→

Join us for a video replay of this insightful discussion on talent management strategies, featuring an esteemed panel with diverse experience.Continue reading→

• The Foundation for the National Institutes of Health Announces the Launch of a Public-Private Partnership to Accelerate ALS Diagnosis and Treatment
• The Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS) will create the largest open data platform for ALS research
• Partnership will enable discovery and development of diagnostic tools, biomarkers, and better treatments

Managed by the FNIH, the Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS) brings together the resources and expertise of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH), the Food and Drug Administration (FDA), Critical Path Institute (C-Path), and other stakeholders from academia, life science companies, foundations, and patient-focused groups to tackle the tremendous challenges of diagnosing, understanding, and treating the disease. AMP ALS is supported by a combined commitment of approximately $60 million.Continue reading→

The proceeds will support the execution of the Phase II/III trial and potential NDA submission for the Nectero EAST System, a Breakthrough Therapy for small to medium-sized AAA.Continue reading→

Enabling rapid, automated microbial identification directly from positive blood culture samplesContinue reading→

With the recent FTC Ruling Banning Non-Compete Agreements, more attention is now now focused on this long standing business practice.  This educational video update on Non-Compete Agreements was hosted by AZBio and presented by Helen Holden of Spencer Fane. Continue reading→

The Center for Advanced Molecular and Immunological Therapies will be led by Deepta Bhattacharya, PhD, a renowned immunologist at the College of Medicine – Tucson.Continue reading→

Continue reading→

House lawmakers today unveiled a new draft of the BIOSECURE Act. Shortly after, BIO President and CEO, John F. Crowley, made the following statement:

“The BIOSECURE bill released in the House today reinforces the national security imperative of the biotechnology industry as a critical strategic asset of the United States of America. It highlights a key vulnerability in our global supply chain and importantly provides a reasonable timeframe for companies to decouple their reliance on China-based biomanufacturing. It ensures during this transition that important biomedical research will not be slowed and that patients will have unimpeded access to life saving medicines.Continue reading→